Dawn L. Hall

1.6k total citations
16 papers, 930 citations indexed

About

Dawn L. Hall is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Dawn L. Hall has authored 16 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Dawn L. Hall's work include Protein Kinase Regulation and GTPase Signaling (4 papers), HIV Research and Treatment (3 papers) and Hepatitis C virus research (3 papers). Dawn L. Hall is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), HIV Research and Treatment (3 papers) and Hepatitis C virus research (3 papers). Dawn L. Hall collaborates with scholars based in United States, Italy and Japan. Dawn L. Hall's co-authors include Lawrence C. Kuo, Paul L. Darke, Sanjeev Munshi, Maria Kornienko, John C. Reid, Zhucheng Yang, Steven S. Carroll, Lloyd Waxman, Jennifer M. Shipman and Joanne E. Tomassini and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Nature Chemical Biology.

In The Last Decade

Dawn L. Hall

16 papers receiving 888 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dawn L. Hall 508 279 258 234 125 16 930
W.W. Prosise 426 0.8× 149 0.5× 323 1.3× 197 0.8× 42 0.3× 13 909
Nathalie Goudreau 687 1.4× 492 1.8× 371 1.4× 206 0.9× 327 2.6× 42 1.5k
Mary H. Hanlon 925 1.8× 283 1.0× 54 0.2× 143 0.6× 210 1.7× 27 1.3k
John T. Randolph 1.1k 2.2× 248 0.9× 292 1.1× 255 1.1× 78 0.6× 39 1.7k
Joke Regts 694 1.4× 126 0.5× 73 0.3× 293 1.3× 30 0.2× 36 1.4k
David H. Perlman 964 1.9× 81 0.3× 126 0.5× 192 0.8× 37 0.3× 20 1.4k
Amartya Basu 457 0.9× 172 0.6× 166 0.6× 104 0.4× 88 0.7× 40 1.2k
Magdeleine Hung 456 0.9× 622 2.2× 315 1.2× 520 2.2× 532 4.3× 38 1.4k
Gessica Filocamo 837 1.6× 78 0.3× 809 3.1× 678 2.9× 100 0.8× 16 1.7k
Eckart Matthes 356 0.7× 297 1.1× 59 0.2× 196 0.8× 224 1.8× 43 701

Countries citing papers authored by Dawn L. Hall

Since Specialization
Citations

This map shows the geographic impact of Dawn L. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn L. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn L. Hall more than expected).

Fields of papers citing papers by Dawn L. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn L. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn L. Hall. The network helps show where Dawn L. Hall may publish in the future.

Co-authorship network of co-authors of Dawn L. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn L. Hall. A scholar is included among the top collaborators of Dawn L. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn L. Hall. Dawn L. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elsen, Nathaniel L., Sangita B. Patel, Dawn L. Hall, et al.. (2017). Insights into activity and inhibition from the crystal structure of human O-GlcNAcase. Nature Chemical Biology. 13(6). 613–615. 73 indexed citations
2.
Harrison, Scott T., Michael S. Poslusney, Zhijian Zhao, et al.. (2015). Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT). ACS Medicinal Chemistry Letters. 6(3). 318–323. 36 indexed citations
3.
Allen, Samantha J., Gopal Parthasarathy, Paul L. Darke, et al.. (2015). Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4. Journal of Biological Chemistry. 290(33). 20360–20373. 13 indexed citations
4.
Rickert, Keith, Sangita B. Patel, Timothy J. Allison, et al.. (2011). Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met. Journal of Biological Chemistry. 286(13). 11218–11225. 30 indexed citations
5.
Soisson, S.M., Sangita B. Patel, Pravien Abeywickrema, et al.. (2010). Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. BMC Structural Biology. 10(1). 16–16. 38 indexed citations
6.
Abeywickrema, Pravien, Sangita B. Patel, Noel Byrne, et al.. (2010). Expression, purification and crystallization of human prolylcarboxypeptidase. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 66(6). 702–705. 11 indexed citations
7.
Sunami, T., Noel Byrne, Ronald E. Diehl, et al.. (2009). Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation. Journal of Biological Chemistry. 285(7). 4587–4594. 46 indexed citations
8.
Rickert, Keith, Noel Byrne, Ronald E. Diehl, et al.. (2008). Structure of Human Prostasin, a Target for the Regulation of Hypertension. Journal of Biological Chemistry. 283(50). 34864–34872. 30 indexed citations
9.
Kornienko, Maria, B. Carpenter, Pravien Abeywickrema, et al.. (2005). Protein Expression Plasmids Produced Rapidly: Streamlining Cloning Protocols and Robotic Handling. Assay and Drug Development Technologies. 3(6). 661–674. 9 indexed citations
10.
Munshi, Sanjeev, Dawn L. Hall, Maria Kornienko, Paul L. Darke, & Lawrence C. Kuo. (2003). Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 Å resolution. Acta Crystallographica Section D Biological Crystallography. 59(10). 1725–1730. 53 indexed citations
11.
Carroll, Steven S., Joanne E. Tomassini, Michele Bosserman, et al.. (2003). Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs. Journal of Biological Chemistry. 278(14). 11979–11984. 281 indexed citations
12.
Munshi, Sanjeev, Maria Kornienko, Dawn L. Hall, et al.. (2002). Crystal Structure of the Apo, Unactivated Insulin-like Growth Factor-1 Receptor Kinase. Journal of Biological Chemistry. 277(41). 38797–38802. 54 indexed citations
13.
Carroll, Steven S., Vinod Sardana, Zhucheng Yang, et al.. (2000). Only a Small Fraction of Purified Hepatitis C RNA-Dependent RNA Polymerase Is Catalytically Competent:  Implications for Viral Replication and in Vitro Assays. Biochemistry. 39(28). 8243–8249. 52 indexed citations
14.
Darke, Paul L., James L. Cole, Lloyd Waxman, et al.. (1996). Active Human Cytomegalovirus Protease Is a Dimer. Journal of Biological Chemistry. 271(13). 7445–7449. 78 indexed citations
15.
Chen, Zhongguo, et al.. (1995). Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials. Journal of Biological Chemistry. 270(37). 21433–21436. 77 indexed citations
16.
Hall, Dawn L. & Paul L. Darke. (1995). Activation of the Herpes Simplex Virus Type 1 Protease. Journal of Biological Chemistry. 270(39). 22697–22700. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026